ReviewIBRO neuroscience reports2025
Recanalization of atherosclerotic stenosis and occlusion of intracranial vertebrobasilar artery.
Review in IBRO neuroscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Elucidating the benefit of drug-eluting stent for symptomatic intracranial atherosclerotic stenosis: Meta-analysis of randomized controlled trials.Surgical neurology international · 2025Review
- Exchange-free single-pass gateway balloon-assisted neuroform atlas stenting for symptomatic high-grade intracranial atherosclerotic stenosis: clinical and angiographic outcomes.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracranial vertebrobasilar atherosclerosis is one of the major causes of posterior circulation ischemic strokes and may result in a high risk of recurrent stroke. Current treatment for vertebrobasilar stenosis comprises aggressive medication and percutaneous transluminal angioplasty and stenting (PTAS). Endarterectomy and intracranial-extracranial bypass surgery may be considered for large artery stenosis in the anterior circulation, but they may be deterred by some technical difficulties and great complication rates in the vertebrobasilar stenoses. PTAS may be good for eliminating the arterial stenosis and preventing recoil of arterial wall after balloon angioplasty alone, however, higher peri-procedural complications and poor follow-up outcomes prevent PTAS as a common treatment strategy. Nonetheless, for selected patients with severe (≥70 %) stenosis and non-acute occlusion of the intracranial vertebrobasilar artery refractory to the best medication, PTAS may be feasible, safe and effective if the treatment approaches and endovascular devices were tailored to the clinic-radiological features of each lesion and patient. Sub-satisfactory stenting recanalization of the stenosis using a balloon < 80 % of the diameter of the nearby normal artery for dilatation of the stenosis and selection of softer and more flexible stents and delivery systems may be advantageous in decreasing the peri-procedural complications. This study reviewed the concept of intracranial vertebrobasilar atherosclerotic stenosis, available treatment modalities, peri-procedural complications, risk factors for endovascular treatment and prognosis, evidence for sub-satisfactory recanalization of the stenosis, and strategies to improve the peri-procedural complications and prognosis with the hope of improving the treatment outcome of endovascular recanalization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.